ClinicalTrials.Veeva

Menu

A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty

Zimmer Biomet logo

Zimmer Biomet

Status

Withdrawn

Conditions

Traumatic Arthritis
Osteoarthritis
Arthritis
Rheumatoid Arthritis

Treatments

Device: Hip Resurfacing System
Device: M2a-Magnum™ Large Metal Articulation

Study type

Interventional

Funder types

Industry

Identifiers

NCT00585988
292-U-010

Details and patient eligibility

About

The primary purpose of this study is to compare early functional outcomes in patients undergoing hip resurfacing and total hip arthroplasty with the M2a-Magnum™ using more objective measures of function.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients requiring hip arthroplasty

Exclusion criteria

  • Patients with sensory, neurological, or general health conditions that alter perception of their limb in space
  • Patients with vestibular disorders

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

1
Other group
Treatment:
Device: Hip Resurfacing System
2
Other group
Treatment:
Device: M2a-Magnum™ Large Metal Articulation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems